BRK-B vs NAD
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
NAD demonstrates strong operational health with a Piotroski F-Score of 7/9, yet it trades at a significant premium to its Graham Number ($8.78) and Intrinsic Value ($8.26). While the Price-to-Book ratio of 0.95 suggests the fund is priced reasonably relative to its net asset value, the payout ratio of 318.21% is a critical red flag indicating that dividends are not supported by current earnings. Technical trends are currently bearish (0/100), which offsets the positive 1-year price performance. The fund remains a viable income vehicle but lacks the valuation support for a bullish growth rating.
Compare Another Pair
Related Comparisons
BRK-B vs NAD: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Nuveen Quality Municipal Income Fund (NAD) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.